| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-234 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-236 |
| filingDate |
2000-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59f299a84228e97f93b9940f8f518485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c13e331452bf54f33905db1183587e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f9666e7b579ffdd57edc130e82d1644
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88f518beb7d6a0663e7377fddc1e491b |
| publicationDate |
2002-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2002052526-A1 |
| titleOfInvention |
Antimicrobial 2-deoxystreptamine compounds |
| abstract |
The present invention is directed to analogs of aminoglycoside compounds of the class having a glycosylated 2-deoxystreptamine (2-DOS) ring as well as their preparation and use as prophylactic or therapeutics against microbial infection. Compounds of the invention comprises at least one aryl, heteroaryl, substituted aryl or substituted heteroaryl group in place of a glycosyl group attached to the 2-deoxystreptamine ring. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004137011-A1 |
| priorityDate |
1999-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |